"El Hospital Universitario Fundación Jiménez Díaz, fundado hace más de 80 años por el Dr. Carlos Jiménez Díaz, cuenta con profesionales de prestigio que llevan a cabo labor asistencial, docente e investigadora. Así, mantiene acuerdos con la Universidad Autónoma de Madrid, entre otras entidades, y cuenta con su propia Escuela de Enfermería y su Instituto de Investigación Sanitaria. Con cerca de 80.000 metros cuadrados, está dotado de la más alta tecnología sanitaria y ofrece una amplia cartera de servicios."

During the past decade, Hospital Universitario Fundación Jiménez Díaz conducted 457 clinical trials. In the 10-year time frame, 457 clinical trials started and 97 clinical trials were completed, i.e. on average, 21.2% percent of trials that started reached the finish line to date. In the past 5 years, 239 clinical trials started and 84 clinical trials were completed. i.e. 35.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Fundación Jiménez Díaz" #1 sponsor was "Janssen Research & Development, LLC" with 36 trials, followed by "Pfizer" with 22 trials sponsored, "Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz" with 21 trials sponsored, "Celgene" with 20 trials sponsored and "PETHEMA Foundation" with 20 trials sponsored. Other sponsors include 424 different institutions and companies that sponsored additional 237 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Fundación Jiménez Díaz" #1 collaborator was "Bristol-Myers Squibb" with 8 trials as a collaborator, "Merck Sharp & Dohme LLC" with 7 trials as a collaborator, "AstraZeneca" with 6 trials as a collaborator, "Eli Lilly and Company" with 6 trials as a collaborator and "AbbVie" with 5 trials as a collaborator. Other collaborators include 244 different institutions and companies that were collaborators in the rest 187 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Fundación Jiménez Díaz" are "Breast Cancer" (14 trials), "Carcinoma, Non-Small-Cell Lung" (13 trials), "Multiple Myeloma" (12 trials), "HIV Infections" (11 trials) and "Neoplasms" (11 trials). Many other conditions were trialed in "Hospital Universitario Fundación Jiménez Díaz" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Fundación Jiménez Díaz" are "Drug" (410 trials), "Other" (48 trials), "Biological" (42 trials), "Device" (33 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (68 trials), "Carboplatin" (30 trials), "Paclitaxel" (18 trials), "Cisplatin" (13 trials) and "Pembrolizumab" (13 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Fundación Jiménez Díaz" are 517 trials for "All" genders, 23 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 259 active trials in "Hospital Universitario Fundación Jiménez Díaz". 4 are not yet recruiting, 162 are recruiting, 92 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 208 completed trials in Hospital Universitario Fundación Jiménez Díaz, 1 suspended trials, and 50 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Fundación Jiménez Díaz, 121 "Phase 1" clinical trials were conducted, 153 "Phase 2" clinical trials and 165 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 31 trials, and there were also 37 trials that are defined as “Not Applicable".

Hospital Universitario Fundación Jiménez Díaz has several departments that took part in Clinical trials: "START Madrid-FJD, Hospital Fundacion Jimenez Diaz" - 27 trials, "Fundacion Jimenez Diaz; Servicio de Oncologia" - 12 trials, "Fundacion Jimenez Diaz; Servicio de Neurología" - 3 trials, "Fundación Jiménez Díaz-Oncology" - 2 trials, "Fundacion Jimenez Diaz; Servicio de Hematologia" - 2 trials